By Andrew Kersley
International B2B and business intelligence group Informa has announced the sale of its Pharma Intelligence operation to private equity firm Warburg Pincus for a fee totalling £1.9bn.
A leading provider of specialist intelligence and data for clinical trials, drug development and regulatory compliance, Pharma Intelligence accounted for 40% of the £305m revenues reported for the company’s Informa Intelligence division in 2020.
Informa will retain a 15% stake in the business going forward and has also announced plans for a new round of share buybacks.
Source: Informa
Deal value: £1.9bn
Country: UK
Status: Announced
No comments:
Post a Comment
For now, we're opening this blog to Anonymous comments. This will continue as long as civility rules. Disagree as you may, just keep it clean and stay on topic. No profanity, and no name calling. We reserve the right to moderate such comments, though the person who made it may come back and reword their message in a more civil way.